TRIM33 and dermatomyositis: Similarly, in dermatomyositis, anti-transcription intermediary factor 1-γ (TIF1-γ) antibodies bind TIF1-γ protein and interfere with its interaction with Smad complexes, thereby aberrantly modulating transcriptional activity of the TGF-β signalling pathway.